No Data
Sojitz, Kosé HD, and others (additional) Rating
Upgrades - Bullish Code Company Name Brokerage Previous Revised -------------------------------------------------- <4061> Denka SBI Securities "Neutral" "Buy" <6273> SMC Daiwa Securities "3" "2" Downgrades - Bearish Code Company Name Brokerage Previous Revised -------------------------------------------------- <9090> AZ-Wa Maruwa HD SBI Securities "Buy" "Neutral"
Suntory BF, Nissan Chemical Industries, etc. (Additional) Rating
Upgrades - Bullish Ratings Code Company Name Securities Firm Previous Revised ----------------------------------------------------- <4063> Shin-Etsu Chemical Mizuho "Neutral" "Buy" <6857> Advantest Mizuho "Neutral" "Buy" <7282> Toyota Tsusho Citigroup "2" "1" <7309> Shimano Nomura "Neutral" "Buy" Target Price Changes Code Company Name Securities Firm Previous Revised --------------------
List of Reversal Stocks [Parabolic Signal Reversal Stocks List]
List of Stocks Recommended for Purchase Market Code Company Name Closing Price SAR Tokyo Stock Exchange Prime <1333> Umios 1302 → 1230 <1377> Sakata Seed 4460 → 4265 <2752> FujiO Food Systems 1120 → 1072 <2784> Alfresa Holdings 2289 → 2132 <3050> DCM Holdings 1582 → 1495 <3150> Grimms 2490 → 2435 <3696> Ceres 2180 → 1958
Teijin, Money Forward, etc. (Additional) Rating
Upgrade - Bullish Code Ticker Company Previous Revised -------------------------------------------------- <9101> NYK Line SBI Securities "Neutral" "Buy" Target Price Change Code Ticker Company Previous Revised -------------------------------------------------- <2780> Komehyo HD Tokai Tokyo 6,400 yen 6,700 yen <2801> Kikkoman
Mitsubishi Gas Chemical 1Q Net Y18.33B Vs Net Y8.41B
Mitsubishi Gas Chemical Co. Inc. (4182.TO) Japan 1st Quarter Ended June 30 GROUP 2026 2025 Revenue Y223.70 bln Y177.98 bln Operating Profit Y27.
Afternoon Session [Notable Movers & Actively Traded Stocks]
*Stella Pharma <4888> 318 +3: Progress in R&D through collaboration with Fujita Health University is viewed as a positive catalyst. *Dynamic Map <336A> 711 -81: Shares under pressure as investors react negatively to Q1 earnings for the fiscal year ending March 2027. *SusMed <4263> 558 -150: Announces full-year results for the fiscal year ending June 2026. *Alue <7043> 938 +58: Announces strong Q2 results for the fiscal year ending December 2026. *Flight Solutions <3753> 218 +31: First quarter operating